Primer pair for identifying lucid ganoderma, kit and application

By designing specific primer pairs and DNA macro-barcode technology, the problem of difficulty in identifying Ganoderma lucidum medicinal materials, spore powder and Chinese patent medicines is solved, accurate and quantitative analysis of Ganoderma lucidum varieties is achieved, and product quality control and safety are improved.

CN119061175APending Publication Date: 2024-12-03TIANJIN UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310650671.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-02
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

It is difficult for the prior art to accurately identify Ganoderma lucidum medicinal materials, Ganoderma lucidum spore powder and Chinese patent medicines, resulting in an increase in inferior and fake products on the market, affecting the effectiveness and safety of Ganoderma lucidum medicinal materials.

Method used

A specific primer pair was designed (upstream primer sequence is 5ʼ-ACACCTGTGCACTTACTGTGG-3ʼ and downstream primer sequence is 5ʼ-GAGATCCGTTGCTGAAAGTTGT-3ʼ) for accurate and quantitative identification of Ganoderma lucidum varieties through PCR amplification and sequencing technology, combined with DNA macro-barcoding technology can detect trace amounts of Ganoderma lucidum ingredients in mixed samples.

Benefits of technology

Accurate identification and quantitative analysis of Ganoderma lucidum medicinal materials, Ganoderma lucidum spore powder and Chinese patent medicines, improve the quality control and safety of Ganoderma lucidum products, can identify different Ganoderma lucidum varieties within a larger threshold range, and simplify detection process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061175A_ABST
    Figure CN119061175A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of traditional Chinese medicine identification, in particular to a primer pair for identifying ganoderma lucidum, a kit and application. The primer pair provided by the invention comprises an upstream primer with a sequence as shown in SEQ ID NO.1 and a downstream primer with a sequence as shown in SEQ ID NO.2; the kit provided by the invention comprises the primer pair. The primer pair is good in qualitative identification capability, and high sensitivity can be obtained by taking the primer as a molecular marker for DNA macro bar code identification, so that the primer pair can realize identification of ganoderma lucidum in different ganoderma lucidum medicinal materials, ganoderma lucidum spore powder and Chinese patent medicines within a large threshold range, and the identification accuracy is high. The method can be used for effectively detecting trace lucid ganoderma components in a mixed sample.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of traditional Chinese medicine identification, and in particular to a primer pair, a kit and an application thereof for identifying ganoderma lucidum. Background Art

[0002] Ganoderma is the dried fruiting body of Ganoderma lucidum (Leyss. exFr.) Karst. or Ganoderma sinense Zhao, Xu et Zhang, a fungus of the Polyporaceae family. It has anti-tumor, anti-aging, antibacterial, immune system enhancement, anti-hypertension and other effects. Its products are mainly sold in the form of Ganoderma decoction pieces, Ganoderma spore powder and Chinese patent medicine. With the discovery of new medicinal effects of Ganoderma and its outstanding health care effects, the demand for Ganoderma has increased significantly, which has also led to an increase in inferior and counterfeit Ganoderma medicinal materials on the market, especially the use of fungal fruiting bodies of the same family but different genus but similar in appearance to Ganoderma as Ganoderma medicinal materials.

[0003] my country has abundant resources of fungi of the same family as Ganoderma lucidum, with 98 species in 4 genera. There are many varieties on the market, and the biological classification is not completely clear. Traditional identification is mainly based on morphological characteristics, but there is intraspecific diversity in morphological characteristics, which is easy to be confused and difficult to distinguish. Ganoderma lucidum spore powder is a mixture and in powder form, so it is more difficult to identify it based on morphological characteristics, and there is no legal quality standard for the identification of Ganoderma lucidum spore powder. The difficulty in identification has seriously affected the effectiveness and safety of Ganoderma lucidum in clinical medicine. Summary of the invention

[0004] In view of the above technical problems, the present invention provides a primer pair, a kit and an application for identifying Ganoderma lucidum. The primer pair and the kit provided in the present application can accurately characterize and quantify the species of Ganoderma lucidum fungi in a single or mixed sample, and can be used to identify the species of Ganoderma lucidum in Ganoderma lucidum medicinal materials, Ganoderma lucidum spore powder and Ganoderma lucidum-containing Chinese patent medicines, and to determine the proportion of different species.

[0005] In order to achieve the above-mentioned object of the invention, the present invention adopts the following technical solutions:

[0006] In a first aspect, the present invention provides a primer pair for identifying Ganoderma lucidum, comprising an upstream primer with a sequence as shown in SEQ ID NO.1 and a downstream primer with a sequence as shown in SEQ ID NO.2.

[0007] The sequence of SEQ ID NO.1 is: 5ˊ-ACACCTGTGCACTTACTGTGG-3ˊ;

[0008] The sequence of SEQ ID NO.2 is: 5'-GAGATCCGTTGCTGAAAGTTGT-3'.

[0009] The above primers are artificially designed based on the regions with obvious variation sites between different individual sequences of Ganoderma lucidum. According to the evaluation of chemical properties, the above primers are not easy to form primer dimers and hairpin structures, and the annealing temperature is moderate, which can ensure the normal progress of PCR reaction.

[0010] The experiments show that the primer pair has good qualitative identification ability and can identify different Ganoderma lucidum fruiting bodies and Ganoderma lucidum spore powder within a large threshold range, as well as Ganoderma lucidum in Chinese patent medicine. In addition, the primer pair can be used as a molecular marker for DNA macrobarcode identification to obtain high sensitivity, and can effectively detect trace Ganoderma lucidum components in mixed samples.

[0011] In a second aspect, the present invention further provides a kit for identifying Ganoderma lucidum, comprising a primer pair consisting of an upstream primer shown in SEQ ID NO.1 and a downstream primer shown in SEQ ID NO.2.

[0012] Preferably, the kit further comprises a PCR buffer, a DNA polymerase and a template DNA, wherein the PCR buffer contains magnesium ions and deoxynucleoside triphosphates (dNTPs). Both the PCR buffer and the DNA polymerase can be selected from commercially available reagents for PCR amplification, for example, Gflex from Bio-Rad Biotechnology Co., Ltd. TM Buffer and Tks Gflex TM DNA Polymerase. The template DNA is the total DNA of the sample to be tested.

[0013] In a third aspect, the present invention also provides the use of the primer pair in identifying the species of Ganoderma lucidum, using the primer pair to identify Ganoderma lucidum through PCR amplification. The fragments obtained by PCR amplification using the primer pair can accurately identify the species of Ganoderma lucidum in Ganoderma lucidum medicinal materials or Ganoderma lucidum spore powder, and can also identify the species of Ganoderma lucidum in Chinese patent medicines containing Ganoderma lucidum.

[0014] Preferably, the specific steps of the application include:

[0015] S1. Extracting total DNA of the sample to be tested;

[0016] S2, using the total DNA as template DNA, and performing PCR amplification with the above primers;

[0017] S3. Sequence the PCR amplification product and determine the species information of the sample to be tested based on the sequencing results.

[0018] Preferably, the reaction system for PCR amplification is:

[0019]

[0020] The amplification reaction conditions were: 98°C, 1 min; 98°C, 10 s, 60°C, 15 s, 68°C, 30 s, 40 cycles; 68°C, 5 min.

[0021] In the PCR amplification reaction system, the concentration of the template DNA can be routinely adjusted according to the effect of PCR amplification.

[0022] Preferably, the specific operation of determining the species information of the sample to be tested according to the sequencing results in S3 includes: performing second-generation sequencing on the PCR amplification product to obtain the amplification product sequence, and performing homology comparison on the obtained sequence using the BOLD database. If the similarity with the Ganoderma lucidum species compared in the BOLD database is greater than 99%, the substance to be tested is the Ganoderma lucidum species.

[0023] In a fourth aspect, the present invention further provides an application of the above primer pair in quantitatively detecting the proportion of different fungal species of the genus Ganoderma in a mixed sample, and the above primer pair is used to quantify the proportion of fungal species of the genus Ganoderma through PCR amplification. When the above primer pair is used for PCR amplification, the amount of amplified product has a significant correlation with the biomass of the specific Ganoderma species in the sample to be tested, and therefore, the proportion of different Ganoderma species can be known through the ratio of the amount of amplified product.

[0024] When the number of samples to be tested is large, mixed sample detection can be achieved by adding tag sequences with different sequences to the 5' end of the upstream and downstream primers before PCR amplification, which simplifies the detection process and shortens the detection time.

[0025] Preferably, the specific steps of the application include:

[0026] S1. Extracting total DNA of the sample to be tested;

[0027] S2, using the total DNA as template DNA, and performing PCR amplification with the above primers;

[0028] S3. Sequence the PCR amplification products, and determine the species information of each Ganoderma fungus species in the sample to be tested based on the sequencing results. The proportion of the sequence numbers of different fungus species is the proportion of different Ganoderma fungus species in the mixed sample.

[0029] Preferably, the reaction system for PCR amplification is:

[0030]

[0031] The amplification reaction conditions were: 98°C, 1 min; 98°C, 10 s, 60°C, 15 s, 68°C, 30 s, 40 cycles; 68°C, 5 min.

[0032] In the PCR amplification reaction system, the concentration of the template DNA can be routinely adjusted according to the effect of PCR amplification. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 This is a gel electrophoresis diagram of the PCR product of the experimental mixture in Example 4 of the present invention;

[0034] Figure 2 The heat map of the relative abundance of the number of sequences of each species and biomass identified in each experimental mixture in Example 4 of the present invention is as follows;

[0035] Figure 3 This is the correlation analysis between the biomass and sequence number of the three species in the seven experimental mixtures in Example 4 of the present invention;

[0036] Figure 4 This is the gel electrophoresis diagram of the PCR product of the Chinese patent medicine in Example 4 of the present invention;

[0037] Figure 5 This is a heat map of the relative abundance of species composition in each sample in Example 4 of the present invention. DETAILED DESCRIPTION

[0038] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0039] Accurate identification of Ganoderma lucidum medicinal materials, Ganoderma lucidum spore powder and Ganoderma lucidum species in Chinese patent medicines is very important for raw material control, product quality control, and product effectiveness and safety of Ganoderma lucidum products. Traditional identification is mainly based on morphological characteristics, but it is difficult to accurately distinguish, especially for powdered Ganoderma lucidum spore powder and Chinese patent medicines that have been processed into different forms. It is even more difficult to identify based on morphological characteristics. Therefore, it is necessary to seek a new method to identify Ganoderma lucidum medicinal materials, Ganoderma lucidum spore powder and Ganoderma lucidum species in Chinese patent medicines.

[0040] DNA molecular identification technology has been widely used in the identification of traditional Chinese medicine, among which DNA macrobarcoding technology can be used to identify mixed traditional Chinese medicine samples. However, the genome sequences of fungi of the same genus and different species are highly conserved. Therefore, when using DNA macrobarcoding technology to identify them, the design of primers is crucial and will directly affect the accuracy of the identification results.

[0041] In order to accurately identify the Ganoderma species in Ganoderma lucidum medicinal materials, Ganoderma lucidum spore powder and Chinese patent medicines by using DNA macrobarcoding technology, the present invention collected 101 Ganoderma lucidum individuals, used the universal primers ITS1 / ITS4 in the fungal ITS region, and obtained the species sequence of the above Ganoderma lucidum individuals through Sanger double-end sequencing and sequence splicing; by studying the above species sequences, the present invention found a region with obvious variable sites between sequences, then designed primers for the region and evaluated the physical and chemical properties, and finally obtained a set of primer pairs consisting of an upstream primer with a sequence as shown in SEQ ID NO.1 and a downstream primer with a sequence as shown in SEQ ID NO.2. It has been verified that the primer pair can accurately identify the Ganoderma species in the sample to be tested, and can be used to determine the proportion of different Ganoderma species in the sample to be tested.

[0042] The following is further described with reference to specific embodiments.

[0043] Example 1

[0044] The embodiment of the present invention provides a primer pair for identifying Ganoderma lucidum, comprising a forward primer with a sequence as shown in SEQ ID NO.1 and a reverse primer with a sequence as shown in SEQ ID NO.2.

[0045] Example 2

[0046] The embodiment of the present invention provides a kit for identifying Ganoderma lucidum, which includes a primer pair consisting of a forward primer with a sequence as shown in SEQ ID NO.1 and a reverse primer with a sequence as shown in SEQ ID NO.2.

[0047] Example 3

[0048] The embodiment of the present invention provides a kit for identifying Ganoderma lucidum, which specifically comprises:

[0049] (1) A primer pair consisting of a forward primer having a sequence as shown in SEQ ID NO.1 and a reverse primer having a sequence as shown in SEQ ID NO.2.

[0050] (2) PCR reaction reagent: Gflex TM Buffer, Tks Gflex TM DNA Polymerase and template DNA.

[0051] Example 4

[0052] This example provides a method for identifying Ganoderma lucidum, using the primer pair in Example 1 to identify Ganoderma lucidum.

[0053] 1. Materials

[0054] 1.1 Sample

[0055] The three different species of Ganoderma lucidum used in this example were all collected from Guanxian County, Shandong Province, including 61 "China Taishan" Ganoderma lucidum, 12 "Korea" Ganoderma lucidum, and 28 "USA" Ganoderma lucidum. The spore powder of the above three Ganoderma lucidum individuals was artificially mixed to obtain 7 experimental mixtures. The biomass of each species in each mixture is shown in Table 1.

[0056] Table 1 Biomass of each species in the experimental mixture

[0057]

[0058]

[0059] Information on the 9 Ganoderma lucidum spore powder samples and 1 Ganoderma lucidum-containing Chinese patent medicine sample used in this example is shown in Table 2.

[0060] Table 2 Information table of Ganoderma lucidum spore powder samples and Chinese patent medicine samples

[0061]

[0062] 1.2 Experimental instruments

[0063] The main instruments used in this example are shown in Table 3.

[0064] Table 3 Main instruments of the experiment

[0065]

[0066]

[0067] 1.3 Experimental Reagents

[0068] The main experimental reagents used in this example are shown in Table 4.

[0069] Table 4 Main experimental reagents

[0070]

[0071] 2. Methods

[0072] 2.1 DNA extraction

[0073] The fungal genomic DNA extraction kit of Solarbio was used for DNA extraction. The specific operation process is as follows:

[0074] (1) Weigh about 30 mg of each sample into a centrifuge tube, add 200 μL of solution A and 20 μL of RNase A, then add 100 mg of glass beads, and shake on a high-speed shaker for about 5 min.

[0075] (2) Add 20 μL of proteinase K, mix well, and incubate in a 55°C water bath for 30 min. During digestion, invert the tube several times to mix well. Centrifuge at 12,000 rpm for 2 min, then transfer the supernatant to a new centrifuge tube. If there is still precipitation, centrifuge again.

[0076] (3) Add 200 μL of solution B to the supernatant and mix well. If there is a white precipitate, place it in a 55°C water bath for 5 min and the precipitate will disappear.

[0077] (4) Add 200 μL of anhydrous ethanol and mix thoroughly (if flocculent precipitate appears at this time, it will not affect DNA extraction). Add all the solution (including flocculent precipitate) to the adsorption column and let it stand for 2 minutes.

[0078] (5) Centrifuge at 12,000 rpm for 1 min, discard the waste liquid, and return the adsorption column to the collection tube;

[0079] (6) Add 600 μL of rinse solution to the adsorption column, centrifuge at 12,000 rpm for 1 min, discard the waste liquid, and then return the adsorption column to the collection tube;

[0080] (7) Repeat step (6);

[0081] (8) Centrifuge at 12,000 rpm for 2 min and place the adsorption column at room temperature for 10 min to remove the residual ethanol in the adsorption material;

[0082] (9) Place the adsorption column in a clean centrifuge tube, add 80 μL of the eluent preheated in a 65°C water bath in the middle of the adsorption membrane, place at room temperature for 5 min, and centrifuge at 12,000 rpm for 1 min;

[0083] (10) The eluate from the previous centrifugation step was added to the adsorption column again, placed at room temperature for 2 min, and centrifuged at 12,000 rpm for 2 min to obtain the DNA of each sample as template DNA.

[0084] The extracted genomic DNA was purified by NanoDrop TM DNA concentration was measured using a spectrophotometer (Thermo Scientific, USA).

[0085] 2.2 Primer information of mini-barcode

[0086] The primers used in this example are the primer pairs provided in Example 1. Detailed information of the primers is shown in Table 5.

[0087] Table 5 Primer information of mini-barcode

[0088]

[0089]

[0090] According to the conventional operation of primer dilution, the above primers were diluted to 10 μM with sterilized purified water.

[0091] 2.3 Amplification and sequencing

[0092] The PCR reaction system is shown in Table 6, and the amplification procedure is shown in Table 7. All samples were repeated three times at the PCR level, A, B, and C, respectively. A negative control was added to each set of PCR experiments (ultrapure water was used instead of template DNA, and the other reagents were consistent with Table 6). After the PCR reaction was completed, the PCR product was observed by 1% agarose gel electrophoresis. Agarose gel electrophoresis was used to detect whether the PCR was successful. The electrophoresis voltage was set to 110V, the electrophoresis time was set to 30min, the PCR product was cut and recovered, and non-specific PCR products and primer dimers were removed. Subsequently, all PCR products in the three repeated experiments were mixed in equimolar amounts. Use the kit Ultra TM The sequencing library was generated using DNA Library Prep Kit for Illumina (NEB, USA). Sequencing was performed on the Illumina NovaSeq platform with a read length of 2×150 bp.

[0093] Table 6 PCR reaction system

[0094]

[0095] Note: The total reaction volume is 50 μL.

[0096] Table 7 Amplification procedures

[0097]

[0098]

[0099] 2.4 Data Processing

[0100] The sequencing company removes the sequencing adapters and performs preliminary quality control on the data from the sequencing machine to generate clean data. For the obtained clean data, FastQC is first used to perform quality detection on the double-end data to observe whether the base quality, length distribution, and removal of adapter contamination of the clean data are qualified. After confirming that the data is qualified, Trimmomatic is used to further screen the clean data for quality, so that the average base quality is not less than 20. The primer sequence is removed using BBMap software, and the filter_phix command of USEARCH is used to remove phix contamination from the sequence; the fastx_uniques algorithm and the option "minuniquesize 12" are used to remove redundancy, so that only one read with exactly the same base sequence is retained; the USEARCHUNOISE3 algorithm is applied to detect and remove chimeras, and the awk command is used to modify the sequence name format. Use USEARCH to cluster OTUs with a similarity of 100% to generate OTU representative sequences, and use the data after removing phix contamination to map the OTU representative sequence to generate an OTU table. Then, QIIME was used to delete OTUs with a relative abundance of less than 0.01% from the OTU table, and the OTU table and OTU representative sequences were regenerated. The OTU representative sequences of the experimental mixture were aligned with the reference sequence (GenBank accession number ON196206-ON196283), and the OTUs with a similarity of 100% were retained. The alignment results were imported into MEGAN COMMUNITY EDITION6.10.8 to export taxonomic information with a similarity threshold of 100%, and the parameters were set as: Min Score: 50.0, Max Expected: 0.01, Min Percent Identity: 100.0, Top Percent: 10.0, Min Support Percent: 0.01, MinSupport: 1, LCA Algorithm: weighted.

[0101] 3. Experimental mixture results

[0102] 3.1 Sample amplification results

[0103] like Figure 1 As shown (in the figure, 1-A to 7-A, 1-B to 7-B, 1-C to 7-C are PCR products of three replicates of the experimental mixture; KA, KB, KC are empty tubes; FA, FB, FC are negative tubes, i.e., tubes with negative controls added), each sample was successfully amplified in the three replicates of the experimental mixture, and the empty tubes and negative tubes were free of contamination.

[0104] 3.2 Sequencing data analysis

[0105] After data processing, a total of 3 OTUs (OTUs were clustered using USEARCH with 100% similarity) with a total of 5,959,576 sequences were obtained. The 3 OTUs were compared with the reference sequence (GenBank accession number ON196206-ON196283), and the identification results were American Ganoderma (MG), Chinese Taishan Ganoderma (TS) and Korean Ganoderma (NH), and the sequence similarity was 100%. The number of sequences contained in each sample and the identification results are shown in Table 8.

[0106] Table 8 Sequence numbers and OTU identification results of each sample in the experimental mixture

[0107]

[0108] 3.3 Qualitative and quantitative ability evaluation

[0109] Figure 2 This is a comparative analysis of the number of sequences of species identified by DNA mini-barcode in 7 experimental mixtures (LZ1, LZ2, LZ3, LZ4, LZ5, LZ6, LZ7) and 3 repeated experiments (A, B, C) and the biomass of each species in the actual mixed samples. In the figure, NH is Korean Ganoderma lucidum, TS is Chinese Taishan Ganoderma lucidum, and MG is American Ganoderma lucidum. The results showed that in the experimental mixture, the species proportions obtained in each repeated experiment were very similar, which shows that the results obtained in this experiment are reproducible. Moreover, this experiment can simultaneously identify Chinese Taishan Ganoderma lucidum, Korean Ganoderma lucidum and American Ganoderma lucidum, even when the species proportions are very different (such as samples LZ5, LZ6 and LZ7, where the biomass of Chinese Taishan Ganoderma lucidum accounts for approximately 93.3%, 3.3% and

[0110] 3.3%, Korean Ganoderma lucidum accounts for approximately 3.3%, 93.3% and 3.3%, and the American Ganoderma lucidum accounts for approximately 3.3%, 3.3% and 93.3%).

[0111] The relative abundance of species composition identified in samples LZ1, LZ2, LZ3, LZ4, and LZ7 (relative abundance is the number of sequences of each species divided by the total number of sequences of each sample) is similar to the biomass species composition ratio, while the relative abundance of species composition identified in samples LZ5 and LZ6 is quite different from the biomass species composition ratio. To further verify the ability of DNA mini-barcode to identify three species, this example conducted a correlation analysis between the sequence number ratio and biomass ratio of three species, namely, Taishan Ganoderma lucidum of China, Korean Ganoderma lucidum, and American Ganoderma lucidum, in 7 experimental mixtures and 3 repeated experiments. Figure 3As shown, the results showed that the proportion of sequence numbers of each species was significantly correlated with biomass (China Taishan Ganoderma: R2=0.9231; Korean Ganoderma: R2=0.9769; American Ganoderma: R2=0.9875), indicating that the mini-barcode can better perform quantitative analysis on the three species in the mixed sample.

[0112] The above results show that: on the one hand, within a larger threshold range (0.033-0.933), the qualitative identification ability of the DNA mini-barcode developed in this experiment is good; on the other hand, the DNA macrobarcode technology used in this experiment has high sensitivity and can effectively detect trace components in mixed samples.

[0113] 4. Application of Mini-barcode in Chinese patent medicine

[0114] 4.1 Sample amplification results

[0115] like Figure 4 As shown (in the figure, 1-A~10-A, 1-B~10-B, 1-C~10-C are PCR products in three repeated experiments; KA, KB, KC are empty tubes; FA, FB, FC are negative tubes), 10 samples were successfully amplified in three repeated experiments, and there was no contamination in the empty tubes and negative tubes, that is, the DNA mini-barcode can be used for the identification of commercially available Ganoderma lucidum products.

[0116] 4.2 Sequencing data analysis

[0117] Through data processing, this experiment obtained a total of 8 OTUs (OTUs were clustered using USEARCH with 100% similarity), totaling 15,676,789 sequences. The number of sequences contained in each sample is shown in Table 9.

[0118] Table 9 Number of sequences for each sample

[0119]

[0120]

[0121] The representative sequences of OTUs were compared with the BOLD database.

[0122] 4.3 Species identification results

[0123] Finally, a total of 7 Ganoderma OTUs and 1 non-Ganoderma OTU Daedaleopsis confragosa were identified. The Ganoderma species identified at the species level were Ganoderma lucidum, Ganoderma resinaceum, and Ganoderma applanatum. In addition, there were 2 OTUs that were only identified at the genus level. Among the above species, Ganoderma lucidum was from the pharmacopoeia, and the other species were from non-pharmacopoeia sources. The species identification results are detailed in Table 10.

[0124] Table 10 Species identification results

[0125]

[0126]

[0127] In order to observe the species composition of each sample, the OTU table was sorted according to the species level, and the relative abundance of the sequence number of each species was calculated. Figure 5 The relative abundance ratio heat map of species in each sample. Through the analysis at the species level, it can be seen that more than 96% of the species identification results of the five spore powder samples MLZ2, MLZ6, MLZ7, MLZ8 and MLZ9 are Ganoderma lucidum, which is the source specified in the pharmacopoeia; the proportion of Ganoderma lucidum in the spore powder sample MLZ1 is higher than 89%; the proportion of Ganoderma lucidum in the Chinese patent medicine sample MLZ10 is higher than 74%; the proportion of Ganoderma lucidum in the spore powder samples MLZ4 and MLZ5 is less than 11%, and there are a large number of Ganoderma applanatum from non-pharmacopoeia sources. There may be adulteration of Ganoderma lucidum in these two samples; in the MLZ3 sample, more than 93% are Ganoderma resinaceum, and there is almost no authentic Ganoderma lucidum. The non-Ganoderma species Daedaleopsis confragosa accounted for less than 0.2% in MLZ4, MLZ5, and MLZ10 samples, and the sequence proportion was very small. It may have been accidentally introduced during the picking, storage, transportation, and processing of Ganoderma lucidum medicinal materials.

[0128] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modification, equivalent substitution or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A primer pair for identifying Ganoderma lucidum, characterized in that: It includes an upstream primer with a sequence as shown in SEQ ID NO.1 and a downstream primer with a sequence as shown in SEQ ID NO.

2.

2. A kit for identifying Ganoderma lucidum, characterized in that: It comprises a primer pair consisting of an upstream primer shown in SEQ ID NO.1 and a downstream primer shown in SEQ ID NO.

2.

3. The kit for identifying Ganoderma lucidum according to claim 2, characterized in that: The kit also includes a PCR buffer, a DNA polymerase and a template DNA, wherein the PCR buffer contains magnesium ions and deoxynucleoside triphosphates.

4. The use of the primer pair according to claim 1 in identifying Ganoderma lucidum varieties, characterized in that: The primer pair according to claim 1 is used to identify Ganoderma lucidum through PCR amplification.

5. The use according to claim 4, characterized in that: The specific steps include: S1. Extracting total DNA of the sample to be tested; S2, using the total DNA as template DNA, and performing PCR amplification using the primer pair of claim 1; S3. Sequence the PCR amplification product and determine the species information of the sample to be tested based on the sequencing results.

6. The use according to claim 5, characterized in that: The reaction system of the PCR amplification is: The amplification reaction conditions were: 98°C, 1 min; 98°C, 10 s, 60°C, 15 s, 68°C, 30 s, 40 cycles; 68°C, 5 min.

7. The use according to claim 5, characterized in that: The specific operation of determining the species information of the sample to be tested according to the sequencing results in S3 includes: performing second-generation sequencing on the PCR amplification product to obtain the amplification product sequence, and using the BOLD database to perform homology comparison on the obtained sequence. If the similarity with the Ganoderma species compared in the BOLD database is greater than 99%, the substance to be tested is the Ganoderma species.

8. Use of the primer pair according to claim 1 in quantitatively detecting the proportion of different fungi species of the genus Ganoderma in a mixed sample, characterized in that: The primer pair of claim 1 is used to quantify the proportion of Ganoderma species through PCR amplification.

9. The use according to claim 8, characterized in that: The specific steps include: S1. Extracting total DNA of the sample to be tested; S2, using the total DNA as template DNA, and performing PCR amplification using the primer pair of claim 1; S3. Sequence the PCR amplification products, and determine the species information of each Ganoderma fungus species in the sample to be tested based on the sequencing results. The proportion of the sequence numbers of different fungus species is the proportion of different Ganoderma fungus species in the mixed sample.

10. The use according to claim 9, characterized in that: The reaction system of the PCR amplification is: The amplification reaction conditions were: 98°C, 1 min; 98°C, 10 s, 60°C, 15 s, 68°C, 30 s, 40 cycles; 68°C, 5 min.